Imaging for NAFLD and NASH Studies
BioTel Research provides expert imaging solutions for clinical trials researching liver therapies. As a leader in imaging based quantification of hepatic fat, we strengthen your trial with unparalleled experience and global operational support.
Quantitative Imaging Analysis for NAFLD and NASH
Our study teams provide quantitative imaging analyses for liver disorders such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), with liver endpoint measurements including hepatic fat, stiffness and fibrosis.
Magnetic resonance imaging – proton density fat fraction (MRI-PDFF) provides a reliable assessment of fat across the entire liver.
Magnetic resonance elastography (MRE) measures liver tissue stiffness by combining MRI imaging with sound waves.